Lodestone Biomedical Inc.
View this filing on EDGAR (filing index, accession 0001665160-24-001643) | All Form C filings by this company on EDGAR
Filing details
| Company | Lodestone Biomedical Inc. | (Form C, issuer information) |
|---|---|---|
| State | NH | (Form C, issuer information) |
| Platform | StartEngine Primary, LLC | (Form C, issuer information) |
| Filing date | 2024-11-18 | (EDGAR filing index) |
| Date of incorporation | 2015-06-17 | (Form C, issuer information) |
| Employees | 1 | (Form C, issuer information) |
| Security offered | Other Class B Common Stock | (Form C, offering information) |
| Price per security | $1 | (Form C, offering information) |
| Target amount | $123,999 | (Form C, offering information) |
| Maximum ask | $1,235,000 | (Form C, offering information) |
| Offering deadline | 2025-02-18 | (Form C, offering information) |
| Platform compensation | 7 - 13 percent | (Form C, offering information) |
Financial summary
Figures are as entered by the company in the financial summary on the cover of its Form C. They are self-reported and unaudited, and they are not taken from the financial statements filed as exhibits to the Form C, which we do not read mechanically.
| Item | Most recent fiscal year | Prior fiscal year | Source |
|---|---|---|---|
| Revenue | $957,211 | $472,056 | (Form C, financial summary) |
| Cost of goods sold | $0 | $0 | (Form C, financial summary) |
| Net income | -$59,274 | -$178,761 | (Form C, financial summary) |
| Taxes paid | $0 | $0 | (Form C, financial summary) |
| Cash and equivalents | $251,910 | $273,369 | (Form C, financial summary) |
| Accounts receivable | $223,878 | $244,278 | (Form C, financial summary) |
| Total assets | $555,177 | $619,603 | (Form C, financial summary) |
| Short-term debt | $20,941 | $50,692 | (Form C, financial summary) |
| Long-term debt | $1,848,928 | $1,787,660 | (Form C, financial summary) |
Mechanical checks that fired
- Net loss in both years. Net income is negative in both fiscal years reported in the Form C financial summary.
- Debt above assets. Short-term plus long-term debt is larger than total assets in the Form C financial summary.
- Platform compensation of 8% or more. The platform compensation stated in the Form C is 8% or more of the offering.
A check means "read this part of the filing closely." It is not a judgment about how the company will do.
Company website as listed in the Form C: https://www.lodestonebiomedical.com/
Want the weekly briefing? Subscribe free.